Patents by Inventor Marion Dahlke

Marion Dahlke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF SERELAXIN TO REDUCE GDF-15
    Publication number: 20190022189
    Abstract: Growth differentiation factor 15 (GDF-15) is a stress-responsive cytokine known to be associated with adverse events in heart failure patients. The use of serelaxin has been shown to affect GDF-15 levels at baseline and decreases in GDF-15 levels over time. Measuring GDF-15 levels allows a healthcare provider to accurately predict pulmonary load in patients with pulmonary congestion.
    Type: Application
    Filed: September 21, 2018
    Publication date: January 24, 2019
    Inventors: Margaret Forney Prescott, Yiming Zhang, Marion Dahlke, Thomas Severin
  • USE OF SERELAXIN TO REDUCE GDF-15
    Publication number: 20170100460
    Abstract: Growth differentiation factor 15 (GDF-15) is a stress-responsive cytokine known to be associated with adverse events in heart failure patients. The use of serelaxin has been shown to affect GDF-15 levels at baseline and decreases in GDF-15 levels over time. Measuring GDF-15 levels allows a healthcare provider to accurately predict pulmonary load in patients with pulmonary congestion.
    Type: Application
    Filed: June 10, 2015
    Publication date: April 13, 2017
    Applicant: NOVARTIS AG
    Inventors: Margaret Forney Prescott, Yiming Zhang, Marion Dahlke, Thomas Severin